University of Edinburgh
Cyanobacterial polysaccharides as broad‑spectrum antivirals: mechanisms and structural determinants of activity
Abstract
dc:description.abstractViruses pose a significant threat, driving the need for new antivirals. Cyanobacteria, commonly used in the nutraceutical industry, represent an underexplored source of compounds with pharmacological potential. This PhD project investigated the properties of extracellular polysaccharides (EPS) from the cyanobacterium Arthrospira platensis. We confirmed the broad-spectrum antiviral activity of EPS against different enveloped viruses’ models, and provided evidence that EPS prevents fusion between the viral envelope and the cellular membrane. We also observed a degree of virucidal activity (the ability to inactivate a viral particle by compromising its structural integrity). While this has been observed with synthetic polymers, this is the first time virucidal activity has been verified in a cyanobacteria-derived polysaccharide. We observed that EPS inhibits non-enveloped viruses (Coxsackievirus and Rotavirus) as well, with preliminary results suggesting direct interaction between the polysaccharide and the viral particle. We analysed the molecular composition of EPS and discovered that A. platensis produces distinct polysaccharide species. By correlating their properties with antiviral potency, we identified key features essential for antiviral activity: abundant sulphated and phosphate groups, high degree of branching along the main polysaccharide backbone, and an enrichment of specific sugar moieties, with 1-4 beta bonds which confer flexibility. We hypothesize the branched, flexible structure of EPS to allow its many sulphate and phosphate groups to establish numerous low-affinity bonds with the viral particle, causing a high-avidity interaction that prevents contact with the viral receptors, but also disrupt the viral envelope. We also explored the correlation of growth conditions of A. platensis with variations in EPS’s antiviral potency and specificity, providing proof of principle that antiviral activity and potency can be enhanced by modifying cultivation conditions. EPS demonstrates minimal cytotoxicity alongside remarkable broad-spectrum antiviral activity. Its extraction utilizes scalable processes that repurpose industrial waste from A. platensis cultivation, ensuring high efficiency, cost-effectiveness, and a minimal environmental footprint, making EPS a promising candidate towards impactful and sustainable broad-spectrum antiviral therapeutics.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Lancerin, Maria Sole Regina
- Advisors dc:contributor.advisor
-
- Sloan, Richard
- McCormick, Alistair
- Molnar, Attila
- Tait-Burkard, Christine
Subjects
dc:subject × 4Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7418